Clinical Trial Update: Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing melphalan with or without Holmium-166 DOTMP, followed by peripheral stem cell transplantation, in patients with multiple myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Alkeran (melphalan)
• Holmium-166 DOTMP (holmium-166 DOTMP)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED